Eurofarma Laboratorios SA - Strategic SWOT Analysis Review
Description
Eurofarma Laboratorios SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.
Scope
Eurofarma Laboratorios SA (Eurofarma), is a pharmaceutical company that manufactures and markets therapeutics. The company offers prescription, over-the-counter (OTC), generic and cancer drugs, hospital drugs, and drugs exempt from prescription. Its products serve all medical specialties and cover various therapeutic classes. Eurofarma's research and development projects focus on antibiotics, metabolism, and obesity, central nervous system, and oncology. The company operates in Argentina, Bolivia, Brazil, Chile, Colombia, Ecuador, Guatemala, Paraguay, Peru, Venezuela, Mexico, Mozambique, and Uruguay. Eurofarma is headquartered in Sao Paulo, Brazil.
Eurofarma Laboratorios SA Key Recent Developments
Apr 30,2026: Eurofarma Presents its Integrated Sustainability Report 2026, Base Year 2025.
Apr 29,2026: Eurofarma Presents Integrated Sustainability Report 2026, Base Year 2025
Mar 05,2026: Eurofarma Releases Sustainability Guide 2026
Jan 23,2026: Bavarian Nordic Signs Distribution Agreement With Eurofarma to Expand Chikungunya Vaccine Access in Brazil
Reasons to Buy
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.
Scope
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
Eurofarma Laboratorios SA (Eurofarma), is a pharmaceutical company that manufactures and markets therapeutics. The company offers prescription, over-the-counter (OTC), generic and cancer drugs, hospital drugs, and drugs exempt from prescription. Its products serve all medical specialties and cover various therapeutic classes. Eurofarma's research and development projects focus on antibiotics, metabolism, and obesity, central nervous system, and oncology. The company operates in Argentina, Bolivia, Brazil, Chile, Colombia, Ecuador, Guatemala, Paraguay, Peru, Venezuela, Mexico, Mozambique, and Uruguay. Eurofarma is headquartered in Sao Paulo, Brazil.
Eurofarma Laboratorios SA Key Recent Developments
Apr 30,2026: Eurofarma Presents its Integrated Sustainability Report 2026, Base Year 2025.
Apr 29,2026: Eurofarma Presents Integrated Sustainability Report 2026, Base Year 2025
Mar 05,2026: Eurofarma Releases Sustainability Guide 2026
Jan 23,2026: Bavarian Nordic Signs Distribution Agreement With Eurofarma to Expand Chikungunya Vaccine Access in Brazil
Reasons to Buy
- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Table of Contents
33 Pages
- List of Tables
- List of Figures
- Section 1 - About the Company
- Eurofarma Laboratorios SA - Key Facts
- Eurofarma Laboratorios SA - Key Employees
- Eurofarma Laboratorios SA - Major Products and Services
- Eurofarma Laboratorios SA - History
- Eurofarma Laboratorios SA - Company Statement
- Eurofarma Laboratorios SA - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Joint Venture
- Section 2 - Company Analysis
- Company Overview
- Eurofarma Laboratorios SA - Business Description
- Other Break-up: Generics
- Performance
- Other Break-up: Institutional
- Performance
- Other Break-up: OTC
- Performance
- Other Break-up: Prescription
- Performance
- Other Break-up: Third Parties
- Performance
- Geographical Segment: Brazil
- Performance
- Geographical Segment: Other Countries
- Performance
- R&D Overview
- Eurofarma Laboratorios SA - SWOT Analysis
- SWOT Analysis - Overview
- Eurofarma Laboratorios SA - Strengths
- Eurofarma Laboratorios SA - Weaknesses
- Eurofarma Laboratorios SA - Opportunities
- Eurofarma Laboratorios SA - Threats
- Eurofarma Laboratorios SA - Key Competitors
- Section 3 - Company's Lifesciences, Power Financial Deals and Alliances
- Eurofarma Laboratorios SA, Pharmaceuticals & Healthcare, Deals By Year, 2020 to YTD 2026
- Eurofarma Laboratorios SA, Pharmaceuticals & Healthcare, Deals By Type, 2020 to YTD 2026
- Eurofarma Laboratorios SA, Recent Deals Summary
- Section 4 - Company's Recent Developments
- Apr 30, 2026: Eurofarma Presents its Integrated Sustainability Report 2026, Base Year 2025.
- Apr 29, 2026: Eurofarma Presents Integrated Sustainability Report 2026, Base Year 2025
- Mar 05, 2026: Eurofarma Releases Sustainability Guide 2026
- Jan 23, 2026: Bavarian Nordic Signs Distribution Agreement With Eurofarma to Expand Chikungunya Vaccine Access in Brazil
- Jun 24, 2025: Eurofarma Announces Launch of eBulas
- Apr 15, 2025: Others: Eurofarma wins award for Best Marketing Strategy
- Section 5 - Appendix
- Methodology
- About GlobalData
- Contact Us
- Disclaimer
- List of Tables
- Eurofarma Laboratorios SA, Key Facts
- Eurofarma Laboratorios SA, Key Employees
- Eurofarma Laboratorios SA, Major Products and Services
- Eurofarma Laboratorios SA, History
- Eurofarma Laboratorios SA, Subsidiaries
- Eurofarma Laboratorios SA, Joint Venture
- Eurofarma Laboratorios SA, Key Competitors
- Eurofarma Laboratorios SA, Pharmaceuticals & Healthcare, Deals By Year, 2020 to YTD 2026
- Eurofarma Laboratorios SA, Pharmaceuticals & Healthcare, Deals By Type, 2020 to YTD 2026
- Eurofarma Laboratorios SA, Recent Deals Summary
- List of Figures
- Eurofarma Laboratorios SA, Pharmaceuticals & Healthcare, Deals By Year, 2020 to YTD 2026
- Eurofarma Laboratorios SA, Pharmaceuticals & Healthcare, Deals by Type, 2020 to YTD 2026
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.

